Subcutaneous Administration of Rituximab (MabThera) and Trastuzumab (Herceptin) Using Hyaluronidase
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2013.371
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2013
Authors
Publisher
Springer Science and Business Media LLC